(Q39003096)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24744163%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

title

The novel thymidylate synthase inhibitor trifluorothymidine (TFT) and TRAIL synergistically eradicate non-small cell lung cancer cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24744163%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24744163%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

author name string

Kaamar Azijli

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24744163%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Ingrid A M van Roosmalen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24744163%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Jorn Smit

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24744163%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Saravanan Pillai

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24744163%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Masakazu Fukushima

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24744163%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Steven de Jong

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24744163%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Godefridus J Peters

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24744163%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Irene V Bijnsdorp

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24744163%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

language of work or name

1 reference

18 April 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24744163%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

14 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24744163%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

volume

73

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24744163%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24744163%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

page(s)

1273-1283

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24744163%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00280-014-2465-1

14 March 2020

exact match

0 references

cites work

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2465-1

New prognostic factors in lung cancer. Biologic prophets of cancer cell aggression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2465-1

Directing cancer cells to self-destruct with pro-apoptotic receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2465-1

TRAIL and apoptosis induction by TNF-family death receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2465-1

Cell death: critical control points

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2465-1

TRAIL therapy in non-small cell lung cancer cells: sensitization to death receptor-mediated apoptosis by proteasome inhibitor bortezomib.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2465-1

Targeting apoptosis pathways in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2465-1

Cellular FLICE-inhibitory protein (c-FLIP) signalling: a key regulator of receptor-mediated apoptosis in physiologic context and in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2465-1

TRAIL receptor targeting therapies for non-small cell lung cancer: current status and perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2465-1

Therapeutic potential of the dual-targeted TAS-102 formulation in the treatment of gastrointestinal malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2465-1

Cell death independent of caspases: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2465-1

Phase 1 study of TAS-102 administered once daily on a 5-day-per-week schedule in patients with solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2465-1

TAS-102 monotherapy for pretreated metastatic colorectal cancer: a double-blind, randomised, placebo-controlled phase 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2465-1

Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2465-1

Synergistic interaction between trifluorothymidine and docetaxel is sequence dependent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2465-1

Thymidine phosphorylase in cancer cells stimulates human endothelial cell migration and invasion by the secretion of angiogenic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2465-1

Imaging systems for westerns: chemiluminescence vs. infrared detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2465-1

Expression of TNF-related apoptosis-inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2465-1

Drug-induced caspase 8 upregulation sensitises cisplatin-resistant ovarian carcinoma cells to rhTRAIL-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2465-1

Cell-cycle checkpoints and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2465-1

Death receptor-4 (DR4) expression is regulated by transcription factor NF-kappaB in response to etoposide treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2465-1

Cardiac glycosides initiate Apo2L/TRAIL-induced apoptosis in non-small cell lung cancer cells by up-regulation of death receptors 4 and 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2465-1

Chemotherapy and TRAIL-mediated colon cancer cell death: the roles of p53, TRAIL receptors, and c-FLIP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2465-1

Role of the TRAIL/APO2-L death receptors in chlorambucil- and fludarabine-induced apoptosis in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2465-1

Nucleoside analogs: molecular mechanisms signaling cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2465-1

Death receptor-induced activation of the Chk2- and histone H2AX-associated DNA damage response pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2465-1

Cell cycle regulation by FasL and Apo2L/TRAIL in human T-cell blasts. Implications for autoimmune lymphoproliferative syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2465-1

Cathepsin B mediates TRAIL-induced apoptosis in oral cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2465-1

Regulated necrosis: the expanding network of non-apoptotic cell death pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2465-1

Autophagy, a novel target for chemotherapeutic intervention of thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2465-1

Thymidylate synthase inhibitors for non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2465-1

Determinants of trifluorothymidine sensitivity and metabolism in colon and lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2465-1

Phase I study to determine the safety and pharmacokinetics of oral administration of TAS-102 in patients with solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2465-1

Phase I study of TAS-102 treatment in Japanese patients with advanced solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2465-1

Mapatumumab, a fully human agonistic monoclonal antibody that targets TRAIL-R1, in combination with gemcitabine and cisplatin: a phase I study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2465-1

Randomized phase II study of dulanermin in combination with paclitaxel, carboplatin, and bevacizumab in advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2465-1